tiprankstipranks
KalVista reports Q2 EPS (91c), consensus (91c)
PremiumThe FlyKalVista reports Q2 EPS (91c), consensus (91c)
23d ago
Is KALV a Buy, Before Earnings?
Premium
Pre-Earnings
Is KALV a Buy, Before Earnings?
25d ago
KalVista Pharmaceuticals Appoints Laurence Reid to Board
Premium
Company Announcements
KalVista Pharmaceuticals Appoints Laurence Reid to Board
1M ago
KalVista presents data showing sebetralstat effectiveness in reducing anxiety
PremiumThe FlyKalVista presents data showing sebetralstat effectiveness in reducing anxiety
3M ago
KalVista reports inducement grants under Nasdaq listing rule
Premium
The Fly
KalVista reports inducement grants under Nasdaq listing rule
3M ago
KalVista submits additional MAAs for sebetralstat for treatment of HAE
Premium
The Fly
KalVista submits additional MAAs for sebetralstat for treatment of HAE
3M ago
KalVista reports Q1 EPS (87c), consensus (91c)
PremiumThe FlyKalVista reports Q1 EPS (87c), consensus (91c)
4M ago
KalVista announces FDA approval of NDA for sebetralstat
Premium
The Fly
KalVista announces FDA approval of NDA for sebetralstat
4M ago
Is KALV a Buy, Before Earnings?
Premium
Pre-Earnings
Is KALV a Buy, Before Earnings?
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100